Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Novo Nordisk reported one counterfeit pen contained the diabetes medicine insulin ... FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, also used ...

Living with type 1 diabetes? Get essential tips, relatable insights, and support tailored for Singaporean parents! Here's to living fully and thriving! #Type1Diabetes ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Some of the cheaper products, like Eli Lilly's $25 Lispro ... its price by 65% to $108 a vial and $162 for a 5-pack of ...

Eli Lilly (LLY) is expected to easily beat ... Indianapolis, IN, USA - June 17, 2014: Researchers at Lilly Research ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best BofA’s top growth stocks with the fastest projected EPS growth rates. For the ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...